全文获取类型
收费全文 | 27445篇 |
免费 | 1863篇 |
国内免费 | 771篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 667篇 |
妇产科学 | 435篇 |
基础医学 | 3005篇 |
口腔科学 | 211篇 |
临床医学 | 2633篇 |
内科学 | 7454篇 |
皮肤病学 | 148篇 |
神经病学 | 1490篇 |
特种医学 | 590篇 |
外科学 | 1819篇 |
综合类 | 4139篇 |
现状与发展 | 4篇 |
预防医学 | 2003篇 |
眼科学 | 257篇 |
药学 | 3468篇 |
15篇 | |
中国医学 | 1128篇 |
肿瘤学 | 563篇 |
出版年
2023年 | 322篇 |
2022年 | 440篇 |
2021年 | 1099篇 |
2020年 | 820篇 |
2019年 | 732篇 |
2018年 | 710篇 |
2017年 | 767篇 |
2016年 | 895篇 |
2015年 | 973篇 |
2014年 | 1656篇 |
2013年 | 1982篇 |
2012年 | 1701篇 |
2011年 | 1844篇 |
2010年 | 1538篇 |
2009年 | 1398篇 |
2008年 | 1417篇 |
2007年 | 1285篇 |
2006年 | 1151篇 |
2005年 | 1018篇 |
2004年 | 883篇 |
2003年 | 751篇 |
2002年 | 567篇 |
2001年 | 594篇 |
2000年 | 457篇 |
1999年 | 389篇 |
1998年 | 328篇 |
1997年 | 317篇 |
1996年 | 313篇 |
1995年 | 275篇 |
1994年 | 272篇 |
1993年 | 224篇 |
1992年 | 182篇 |
1991年 | 195篇 |
1990年 | 185篇 |
1989年 | 159篇 |
1988年 | 170篇 |
1987年 | 154篇 |
1986年 | 149篇 |
1985年 | 219篇 |
1984年 | 195篇 |
1983年 | 118篇 |
1982年 | 157篇 |
1981年 | 143篇 |
1980年 | 146篇 |
1979年 | 121篇 |
1978年 | 93篇 |
1977年 | 96篇 |
1976年 | 77篇 |
1975年 | 57篇 |
1973年 | 73篇 |
排序方式: 共有10000条查询结果,搜索用时 290 毫秒
11.
12.
【摘要】 目的 了解社区中老年人群的血脂、血糖现状水平,探讨其与性别和年龄的关系,为本地区心脑血管疾病、糖尿病等疾病的防治提供诊疗依据。方法 对我市38078名社区居民采集清晨空腹血清标本,检测血糖(GLU)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL C)和低密度脂蛋白胆固醇(LDL C)的结果,并对其进行年龄、性别分组统计分析。结果 不同性别和年龄组间的血脂、血糖水平差异有统计学意义(P<005),74~89岁年龄组血脂、血糖总体水平高于其他各年龄组(P<005);女性血脂水平普遍高于男性(P<005)。结论 中老年人群血脂、血糖异常率高,应定期对中老年人进行血脂、血糖监测,开展宣传教育活动,提高自我保健意识,预防高血脂、高血糖的发生和发展。 相似文献
13.
14.
15.
16.
17.
糖尿病已成为全球威胁人类健康的三大慢性非传染性疾病之一。需要外科手术的患者占所有糖尿病患者的25%,其围手术期病死率、并发症以及住院时间较正常人明显增加,因此对于糖尿病患者围手术期的处理方案显得尤为重要。但目前对于围手术期血糖控制范围仍众说纷纭,综合各研究结论,笔者认为将血糖控制在7.8~10 mmol/L是一个较为理想的范围。在患者术前、术中及术后应联合多学科制定各项相应的治疗方案,围手术期尤为注意避免患者发生低血糖和电解质紊乱的发生。也亟待后续大规模的随机对照试验进一步确定有效的血糖控制目标。 相似文献
18.
John P. Sundberg Kathleen A. Silva Victoria E. Kennedy John J. Wilson Nicholas E. Gott Beth A. Sundberg Derry C. Roopenian 《Experimental dermatology》2019,28(9):1091-1093
2‐deoxy D‐glucose (2DG) was tested for efficacy in treating alopecia areata using the C3H/HeJ skin graft model. 2DG has proven to be efficacious in treatment of various mouse models of autoimmunity with minimal serious side effects noted. This agent has been shown to normalize abnormally activated T‐cell populations while also preventing cell surface expression of NKG2D; key factors defining alopecia areata disease progression. Daily oral ingestion of 2DG via drinking water to mice with patchy or diffuse alopecia areata for 16 weeks failed to prevent expansion of alopecia or cause regrowth of hair in treated mice. Histologically, there were no differences between treated and control groups. These results indicate that, while 2DG is effective for some autoimmune diseases, it was not efficacious for the cell‐mediated autoimmune mouse disease, alopecia areata. 相似文献
19.
Philippe A. Eigenmann Motohiro Ebisawa Matthew Greenhawt Jonathan O’B Hourihane Tamara T. Perry Benjamin C. Remington Robert A. Wood 《Pediatric allergy and immunology》2021,32(4):658-666
Risk is a concept inherent in every medical procedure. It can be defined as the probability of an adverse event in a defined population over a specified period of time. In the frame of food allergy management, it might be related to a diagnostic procedure, a treatment, or the consumption of foods. The risk of an adverse event can also be augmented by individual factors. This rostrum article discusses various aspects faced by children with food allergies in the light of risk, and their practical implications. Identifying personal risks for severe reaction, such as unstable asthma, and correcting them whenever possible also contribute to a reduction of the risk inherent to food allergy. Among the facets discussed, oral food challenges (OFC) are the most common diagnostic procedures implying an inherent risk. The risk of OFCs can be minimized by correct indication and timing of the test, a safe setting, as well as by ensuring that the patient is otherwise well without potential stressor potentially increasing the risk of a more severe reaction. Oral immunotherapy (OIT) has been studied as a potential treatment for increasing the threshold dose for reaction, and thus reducing the risk of accidental reaction. Nevertheless, the procedure is not devoid of risk as the patients may and do often react during the course of the procedure. Ingestion of trace amounts in processed foods, mainly in community settings such as restaurants, schools, or day care, represents a potential risk of reactions, although for a minority of patients. Precautionary allergen labeling (PAL) is a widespread strategy to reduce the potential risk of reactions due to traces. However, PAL is currently inefficient due to inconsistent labeling, also not indicating a clear maximum amount possibly present in the manufactured food. Finally, cost-effectiveness needs to be considered in risk management, as many risk reduction procedures are clearly not cost-effective. 相似文献
20.
B. C. Beaudette-Zlatanova B. Whalen D. Zipris H. Yagita J. Rozing H. Groen C. D. Benjamin T. Hunig H. A. Drexhage M. J. Ansari J. Leif J. P. Mordes D. L. Greiner M. H. Sayegh A. A. Rossini 《American journal of transplantation》2006,6(5P1):894-902
Costimulatory signals regulate T-cell activation. To investigate the role of costimulation in autoimmunity and transplantation, we studied the BB rat model of type 1 diabetes. Diabetes-prone BB (BBDP) rats spontaneously develop disease when 55–120 days of age. We observed that two anti-CD28 monoclonal antibodies (mAb) with different functional activities completely prevented diabetes in BBDP rats. Anti-CD154 mAb delayed diabetes, whereas treatment with CTLA4-Ig or anti-CD80 mAb accelerated disease. Anti-CD86 or anti-CD134L mAbs had no effect. Diabetes resistant BB (BBDR) rats are disease-free, but >95% of them develop diabetes after treatment with polyinosinic-polycytidylic acid and an mAb that depletes Treg cells. In the induced BBDR model, anti-CD154 mAb delayed onset of diabetes, whereas CTLA4-Ig, anti-CD134L or either of the anti-CD28 mAbs had little or no effect. In contrast, blockade of the CD134-CD134L pathway was highly effective for preventing autoimmune recurrence against syngeneic islet grafts in diabetic BBDR hosts. Blockade of the CD40-CD154 pathway was also effective, but less so. These data suggest that the effectiveness of costimulation blockade in the treatment of type 1 diabetes is dependent on both the costimulatory pathway targeted and the mechanism of induction, stage, intensity and duration of the pathogenic process. 相似文献